Secondary Prevention of Osteoporotic Fractures: a Multiple Center Fracture Liaison Service in Greece
A Multiple Center, Prospective Study Targeting the Secondary Prevention of Fractures in Greece: Evaluation of the Fracture Liaison Service in Multiple Hospital Settings
1 other identifier
observational
397
1 country
4
Brief Summary
This is multiple center, prospective study aiming to investigate the tracking and outcome of patients attending Greek General hospitals with low-trauma fractures. Secondary end-points were to facilitate the implementation of coordinated, multi-disciplinary models of care for secondary fracture prevention, and to monitor osteoporosis treatment initiation, osteoporosis treatment persistence at 12 months, compliance, and subsequent fractures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2015
Typical duration for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2015
CompletedFirst Submitted
Initial submission to the registry
December 12, 2015
CompletedFirst Posted
Study publicly available on registry
December 22, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 7, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 7, 2017
CompletedFebruary 23, 2018
February 1, 2018
2.7 years
December 12, 2015
February 22, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Participation rate in the FLS program
Participation rate in the FLS program of patients with low-trauma fractures
2 years
Secondary Outcomes (3)
Percentage of patients initiating osteoporosis treatment
2 years
percentage of patients experiencing subsequent fractures
2 years
osteoporosis treatment adherence at 24 months [measured by Medication Possession Ratio (MPR)]
2 years
Study Arms (1)
patients with low-energy fracture(s)
The study will include patients from pre-defined groups of individuals (postmenopausal, perimenopausal, male, and steroid induced osteoporosis) who would be anyway eligible to receive treatment for their condition according to standard medical practice and Greek treatment guidelines. Drug: anti-osteoporotic medication (bisphosphonates, denosumab, strontium ranelate, teriparatide, SERMs)
Interventions
check previous information
Eligibility Criteria
Patients over 50 years old with low energy fractures
You may qualify if:
- Hospitalized patients and Outpatients over 50 years old with low energy fractures (low energy fracture is defined as a fracture resulting from minimal trauma such as falling from standing height or less).
You may not qualify if:
- Presence of osteomalacia and/or other clinical entities predisposing to low energy fractures, apart from osteoporosis, such as primary or secondary hyperparathyroidism, Paget's disease of bone, osteogenesis imperfecta and paraplegia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS, MEDICAL SCHOOL, 2nd DEPARTMENT OF ORTHOPAEDIC SURGERY
Athens, Attica, 14233, Greece
Democritus University of Thrace, School of Medicine, Department of Orthopaedic Surgery
Alexandroupoli, Evros, 68100, Greece
Orthopaedic Department, Faculty of Medicine, School of Health Sciences, University of Thessalia
Larissa, 41110, Greece
Aristotle University of Thessaloniki, 3rd University Orthopaedic Department, Papageorgiou General Hospital
Thessaloniki, 56403, Greece
Related Publications (5)
Marsh D, Akesson K, Beaton DE, Bogoch ER, Boonen S, Brandi ML, McLellan AR, Mitchell PJ, Sale JE, Wahl DA; IOF CSA Fracture Working Group. Coordinator-based systems for secondary prevention in fragility fracture patients. Osteoporos Int. 2011 Jul;22(7):2051-65. doi: 10.1007/s00198-011-1642-x. Epub 2011 May 24.
PMID: 21607807BACKGROUNDMcLellan AR, Gallacher SJ, Fraser M, McQuillian C. The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporos Int. 2003 Dec;14(12):1028-34. doi: 10.1007/s00198-003-1507-z. Epub 2003 Nov 5.
PMID: 14600804BACKGROUNDCooper MS, Palmer AJ, Seibel MJ. Cost-effectiveness of the Concord Minimal Trauma Fracture Liaison service, a prospective, controlled fracture prevention study. Osteoporos Int. 2012 Jan;23(1):97-107. doi: 10.1007/s00198-011-1802-z. Epub 2011 Sep 28.
PMID: 21953475BACKGROUNDMakras P, Vaiopoulos G, Lyritis GP; Greek National Medicine Agency. 2011 guidelines for the diagnosis and treatment of osteoporosis in Greece. J Musculoskelet Neuronal Interact. 2012 Mar;12(1):38-42. No abstract available.
PMID: 22373950BACKGROUNDDehamchia-Rehailia N, Ursu D, Henry-Desailly I, Fardellone P, Paccou J. Secondary prevention of osteoporotic fractures: evaluation of the Amiens University Hospital's fracture liaison service between January 2010 and December 2011. Osteoporos Int. 2014 Oct;25(10):2409-16. doi: 10.1007/s00198-014-2774-6. Epub 2014 Jul 1.
PMID: 24980182BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christos Kosmidis, MD, Phd
Hellenic Society for the Study of Bone Metabolism
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 12, 2015
First Posted
December 22, 2015
Study Start
April 1, 2015
Primary Completion
December 7, 2017
Study Completion
December 7, 2017
Last Updated
February 23, 2018
Record last verified: 2018-02